Mitsubishi UFJ Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,600	Closed	-$180K	–	840
2017 Q3	$180K	Hold	1,600	–	–	﹤0.01%	752
2017 Q2	$179K	Sell	1,600 -500	-24%	-$56.5K	﹤0.01%	761
2017 Q1	$245K	Sell	2,100 -100	-5%	-$11.1K	0.01%	742
2016 Q4	$237K	Hold	2,200	–	–	0.01%	739
2016 Q3	$243K	Hold	2,200	–	–	0.01%	731
2016 Q2	$320K	Buy	2,200 +1,100	+100%	+$156K	0.01%	721
2016 Q1	$158K	Buy	1,100 +100	+10%	+$14.2K	﹤0.01%	753
2015 Q4	$155K	Buy	+1,000	New	+$146K	﹤0.01%	757

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

Mitsubishi UFJ Asset Management's TARO Position: Q4 2017 in Review

Mitsubishi UFJ Asset Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2017, closing a stake of 1,600 shares — an estimated $180K sold.

Mitsubishi UFJ Asset Management first reported a position in TARO in Q4 2015 and held it in 8 quarters. The position peaked at $320K in Q2 2016. 127 funds tracked by Wall St. Rank hold TARO as of Q4 2017.

Mitsubishi UFJ Asset Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2017 after selling out during the quarter.
Mitsubishi UFJ Asset Management sold 1,600 Taro Pharmaceutical Industries Ltd. shares in Q4 2017, an estimated $180K.
Mitsubishi UFJ Asset Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2015 and held it in 8 quarters.
Mitsubishi UFJ Asset Management's Taro Pharmaceutical Industries Ltd. position peaked at $320K in Q2 2016.
127 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2017.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q4 2017, filed 6 Feb 2018.